First Hawaiian Bank Ionis Pharmaceuticals Inc Transaction History

First Hawaiian Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 15, 2019	SELL	$62.09 - $86.14 $72,893 - $101,128	-1,174 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$52.92 - $81.17 $17,886 - $27,435	-338 Reduced 22.35%	1,174 $95,000
Q4 2018 Jan 11, 2019	SELL	$43.37 - $59.54 $17,564 - $24,113	-405 Reduced 21.13%	1,512 $81,000
Q3 2018 Oct 16, 2018	BUY	$42.88 - $53.7 $82,200 - $102,942	1,917 New	1,917 $99,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.